S100A9 and ischemic stroke: Recently, in an experimental model of transient focal ischemia, inhibition of S100A9 reduced infarct volume and brain swelling [22] and a therapeutic vaccine against MRP14 (S100A9) resulted in thrombosis inhibition in a murine model of ischemic stroke [11].